PIRS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pieris Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 12.0296 USD -27.16% Market Closed

Market Cap: $100.1m

	Pieris Pharmaceuticals Inc NASDAQ:PIRS	US
R	Rio Tinto PLC XMUN:RIO1	UK
	Sampo Oyj F:SMP0	FI
P	Paradox Interactive AB (publ) F:ETA	SE
	Covivio SA F:F5D	FR
	Warner Bros Discovery Inc NASDAQ:WBD	US
	Paradigm Biopharmaceuticals Ltd ASX:PAR	AU
C	Cadence Design Systems Inc XETRA:CDS	US
	Canara Bank Ltd NSE:CANBK	IN

Profitability Summary

Pieris Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 339%

Negative 3Y Average Operating Margin

-282%

Declining Operating Margin

-97% > -1 339%

Negative Net Margin

-1 180%

Negative 3Y Average Net Margin

-255%

Declining Net Margin

-81% > -1 180%

Negative Free Cash Flow Margin

-2 070%

Negative 3Y Average Free Cash Flow Margin

-456%

Declining Free Cash Flow Margin

-139% > -2 070%

Negative ROE

-68%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-148%

Declining ROIC

-114% > -299%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.